|Articles|October 13, 2009
From A to ZeeCRO
Advertisement
Following the divestiture of its US Pharmaceutical Development Services business which included the rights to the AAIPharma name, AAIPharma Inc. has changed its name to ZeeCRO Inc.
ZeeCRO Inc. continues to provide early and late stage development services to its customers worldwide. These services include: Integrated early development services (EU), Pharmaceutical analysis (EU), Clinical trial supplies (EU, SA), Phase 1 (EU), Bioanalysis(NA, EU), Global clinical development services and Oncology development consulting.
The new global headquarters for ZeeCRO is located in Cary, North Carolina, USA.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Real-Time Trials Need More Than AI: Why Operational Trial Infrastructure Matters
2
ACT Brief: Commercial Strategy Shaping Early Clinical Development, Real-Time Trials Require Operational Infrastructure, and AI Site Engagement Gap
3
FDA Makes Case for Overhauling Early Clinical Development to Reclaim US Leadership
4
ACT Brief: Funding Gaps and Indication Decisions in Early-Stage Programs, Recruitment Funnel Leak Diagnosis, and Mega-Merger Speculation Denial
5